Organon Pharma Indonesia Tbk. vs VKTR Teknologi Mobilitas Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while VKTR Teknologi Mobilitas Tbk. trades at Rp795 (market cap 35.22T, 51.61M 24h volume). The key difference: VKTR Teknologi Mobilitas Tbk. is far larger — about 337.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | VKTR | |
|---|---|---|
Market Cap | 104.4B | 35.22T |
Volume | — | 51.61M |
Lot | — | 516.11K |
Turnover | — | 40.37B |
Average Price | — | 782.19 |
Value | — | 40.37B |
Indicative Equilibrium Price | — | 795 |
Indicative Equilibrium Volume | — | 19.16K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT VKTR Teknologi Mobilitas Tbk (formerly PT Bakrie Steel Industries) (the Company) wasestablished in the Republic of Indonesia based on Notarial Deed No. 6 dated November 23, 2007Notary Firdhonal S.H. PT Bakrie & Brothers Tbk, incorporated in the Republic of Indonesia, is the parent entity of the Company. The Company is part of the Bakrie Group.
Read more on VKTR →